On Monday, Verizon Communications Inc. (NYSE:VZ)’s shares inclined 0.77% to $45.91.
Stolen medical information is a much more widespread issue than formerly thought, affecting 18 out of 20 industries examined, according to the just released Verizon 2015 Protected Health Information Data Breach Report. Yet, most organizations outside of the healthcare sector do not realize they even hold this type of data. Common sources of protected health information are employee records (counting workers’ compensation claims) or information for wellness programs and are generally not well protected.
These findings are part of a first-time report from Verizon’s Data Breach Investigations Report (DBIR) team that provides a detailed analysis of confirmed PHI* breaches involving more than 392 million records and 1,931 incidents across 25 countries.
“Many organizations are not doing enough to protect this highly sensitive and confidential data,” said Suzanne Widup, senior analyst and lead author for the Verizon Enterprise Solutions report. “This can lead to noteworthy consequences impacting an individual and their family and increasing healthcare costs for governments, organizations and individuals. Protected health information is highly coveted by cybercriminals.”
Verizon Communications Inc., through its auxiliaries, provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies worldwide.
3M Co (NYSE:MMM)’s shares gained 0.38% to $147.48. The last trading range of 3M Co (NYSE:MMM) ranges between $146.69 and $148.33. The EPS of the company stands at $7.74. The 52-week range shows that the stock reached higher at $170.50 while its lower range is $134.00 in the last 52-weeks. The average volume of the company is at 2.65 million with the Outstanding Shares of 615.71 million. The market capitalization of the company is $90.46 billion. The Beta of the company stands at 1.12 with the RSI (Relative Strength Index) of 35.73.
3M Company operates as a diversified technology company worldwide. Its Industrial segment offers tapes; coated, non-woven, and bonded abrasives; adhesives; ceramics; sealants; specialty materials; filtration products; closure systems for personal hygiene products; acoustic systems products; automotive components; abrasion-resistant films; structural adhesives; and paint finishing and detailing products.
Orexigen Therapeutics, Inc. (NASDAQ:OREX)‘s shares dipped -1.64% to $1.80. Orexigen Therapeutics, Inc. (NASDAQ:OREX) is now worth about $229.47 billion. The share price has made a 6.51% gain in the past 5 days and has lost -70.3% since 2015 kicked off. Analysts are forecasting EPS growth of -0.40% for next fiscal year. The stock trades with a beta of 2.65. The stock price is below by -58.04% as contrast to the average price over the last 200 days.
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.